Fibromyalgia and related conditions

Mayo Clinic Proceedings

Volumn 90, Issue 5, 2015, Pages 680-692

  Clauw, Daniel J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CYCLOBENZAPRINE; DULOXETINE; FLUOXETINE; GABAPENTIN; MILNACIPRAN; NABILONE; PARACETAMOL; PAROXETINE; PREGABALIN; SERTRALINE; TRAMADOL;

ACUPUNCTURE; CAUSAL ATTRIBUTION; CHRONIC PAIN; CLINICAL DECISION MAKING; COGNITIVE THERAPY; COMORBIDITY; CONFERENCE PAPER; DRUG EFFECT; FIBROMYALGIA; HUMAN; KINESIOTHERAPY; LIFESPAN; MEDICAL RESEARCH; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SOCIAL ASPECT; TAI CHI; TREATMENT PLANNING; YOGA; COMPLICATION;

FIBROMYALGIA; HUMANS;

EID: 84929485601     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2015.03.014     Document Type: Conference Paper

References (86)

1. F. Wolfe, K. Ross, J. Anderson, I.J. Russell, and L. Hebert The prevalence and characteristics of fibromyalgia in the general population Arthritis Rheum 38 1 1995 19 28
2. G.T. Jones, F. Atzeni, and M. Beasley The prevalence of fibromyalgia in the general population: a comparison of the american college of rheumatology 1990, 2010, and modified 2010 classification criteria Arthritis Rheumatol 65 2 2015 568 575
3. A. Vincent, B.D. Lahr, and F. Wolfe Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project Arthritis Care Res (Hoboken) 65 5 2013 786 792
4. F. Wolfe, K. Ross, J. Anderson, and I.J. Russell Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms J Rheumatol 22 1 1995 151 156
5. J. McBeth, and K. Jones Epidemiology of chronic musculoskeletal pain Best Pract Res Clin Rheumatol 21 3 2007 403 425
6. J.I. Hudson, and H.G. Pope The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain Baillieres Clin Rheumatol 8 4 1994 839 856
7. L.A. Aaron, and D. Buchwald A review of the evidence for overlap among unexplained clinical conditions Ann Intern Med 134 9, Pt 2 2001 868 881
8. J.W. Warren, F.M. Howard, and R.K. Cross Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome Urology 73 1 2009 52 57
9. D.A. Williams, and D.J. Clauw Understanding fibromyalgia: lessons from the broader pain research community J Pain 10 8 2009 777 791
10. I. Tracey, and M.C. Bushnell How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J Pain 10 11 2009 1113 1120
11. C.J. Woolf Central sensitization: implications for the diagnosis and treatment of pain Pain 152 3, suppl 2011 S2 S15
12. F. Wolfe, J. Anderson, and D. Harkness A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia Arthritis Rheum 40 9 1997 1560 1570
13. L.M. Arnold, J.I. Hudson, and E.V. Hess Family study of fibromyalgia Arthritis Rheum 50 3 2004 944 952
14. K.L. Holliday, and J. McBeth Recent advances in the understanding of genetic susceptibility to chronic pain and somatic symptoms Curr Rheumatol Rep 13 6 2011 521 527
15. K. Kato, P.F. Sullivan, B. Evengård, and N.L. Pedersen A population-based twin study of functional somatic syndromes Psychol Med 39 3 2009 497 505
16. D. Buskila, F. Atzeni, and P. Sarzi-Puttini Etiology of fibromyalgia: the possible role of infection and vaccination Autoimmun Rev 8 1 2008 41 43
17. S.A. McLean, L. Diatchenko, and Y.M. Lee Catechol O-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision J Pain 12 1 2011 101 107
18. J.D. Lewis, E.M. Wassermann, W. Chao, A.E. Ramage, D.A. Robin, and D.J. Clauw Central sensitization as a component of post-deployment syndrome NeuroRehabilitation 31 4 2012 367 372
19. K. Phillips, and D.J. Clauw Central pain mechanisms in rheumatic diseases: future directions Arthritis Rheum 65 2 2013 291 302
20. C.J. Woolf, and S.W. Thompson The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states Pain 44 3 1991 293 299
21. F. Wolfe, H.A. Smythe, and M.B. Yunus The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia; report of the Multicenter Criteria Committee Arthritis Rheum 33 2 1990 160 172
22. F. Petzke, R.H. Gracely, K.M. Park, K. Ambrose, and D.J. Clauw What do tender points measure? Influence of distress on 4 measures of tenderness J Rheumatol 30 3 2003 567 574
23. F. Petzke, D.J. Clauw, K. Ambrose, A. Khine, and R.H. Gracely Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation Pain 105 3 2003 403 413
24. R.E. Harris, and D.J. Clauw How do we know that the pain in fibromyalgia is "real"? Curr Pain Headache Rep 10 6 2006 403 407
25. R.H. Gracely, F. Petzke, J.M. Wolf, and D.J. Clauw Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia Arthritis Rheum 46 5 2002 1333 1343
26. D.B. Cook, G. Lange, D.S. Ciccone, W.C. Liu, J. Steffener, and B.H. Natelson Functional imaging of pain in patients with primary fibromyalgia J Rheumatol 31 2 2004 364 378
27. M. Ploner, M.C. Lee, K. Wiech, U. Bingel, and I. Tracey Prestimulus functional connectivity determines pain perception in humans Proc Natl Acad Sci U S A 107 1 2010 355 360
28. V. Napadow, L. LaCount, K. Park, S. As-Sanie, D.J. Clauw, and R.E. Harris Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity Arthritis Rheum 62 8 2010 2545 2555
29. V. Napadow, J. Kim, D.J. Clauw, and R.E. Harris Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia Arthritis Rheum 64 7 2012 2398 2403
30. K.B. Jensen, R. Loitoile, and E. Kosek Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network Mol Pain 8 2012 32
31. K.B. Jensen, E. Kosek, and F. Petzke Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain Pain 144 1-2 2009 95 100
32. R.E. Harris Elevated excitatory neurotransmitter levels in the fibromyalgia brain Arthritis Res Ther 12 5 2010 141
33. Y.P. Maneuf, J. Hughes, and A.T. McKnight Gabapentin inhibits the substance P-facilitated K(+)-evoked release of [(3)H]glutamate from rat caudial trigeminal nucleus slices Pain 93 2 2001 191 196
34. B.R. Foerster, M. Petrou, and R.A. Edden Reduced insular γ-aminobutyric acid in fibromyalgia Arthritis Rheum 64 2 2012 579 583
35. I.J. Russell, A.J. Holman, T.J. Swick, S. Alvarez-Horine, Y.G. Wang, D. Guinta Sodium Oxybate 06-008 FM Study Group Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study Pain 152 5 2011 1007 1017
36. C.H. Kim, A. Vincent, and D.J. Clauw Association between alcohol consumption and symptom severity and quality of life in patients with fibromyalgia Arthritis Res Ther 15 2 2013 R42
37. A.D. Craig How do you feel? Interoception: the sense of the physiological condition of the body Nat Rev Neurosci 3 8 2002 655 666
38. J.C. Brooks, and I. Tracey The insula: a multidimensional integration site for pain Pain 128 1-2 2007 1 2
39. M.B. Yunus Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes Semin Arthritis Rheum 36 6 2007 339 356
40. K. Ablin, and D.J. Clauw From fibrositis to functional somatic syndromes to a bell-shaped curve of pain and sensory sensitivity: evolution of a clinical construct Rheum Dis Clin North Am 35 2 2009 233 251
41. P.B. Wood, P. Schweinhardt, and E. Jaeger Fibromyalgia patients show an abnormal dopamine response to pain Eur J Neurosci 25 12 2007 3576 3582
42. R.E. Harris, D.J. Clauw, D.J. Scott, S.A. McLean, R.H. Gracely, and J.K. Zubieta Decreased central mu-opioid receptor availability in fibromyalgia J Neurosci 27 37 2007 10000 10006
43. J. Younger, and S. Mackey Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study Pain Med 10 4 2009 663 672
44. L.J. Crofford The hypothalamic-pituitary-adrenal axis in the pathogenesis of rheumatic diseases Endocrinol Metab Clin North Am 31 1 2002 1 13
45. F. Petzke, and D.J. Clauw Sympathetic nervous system function in fibromyalgia Curr Rheumatol Rep 2 2 2000 116 123
46. D.J. Clauw, and G.P. Chrousos Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms Neuroimmunomodulation 4 3 1997 134 153
47. V. Maletic, and C.L. Raison Neurobiology of depression, fibromyalgia and neuropathic pain Front Biosci (Landmark Ed) 14 2009 5291 5338
48. S.H. Kim, D.H. Kim, D.H. Oh, and D.J. Clauw Characteristic electron microscopic findings in the skin of patients with fibromyalgia - preliminary study Clin Rheumatol 27 3 2008 407 411
49. N. Üçeyler, D. Zeller, and A.K. Kahn Small fibre pathology in patients with fibromyalgia syndrome Brain 136 Pt 6 2013 1857 1867
50. F. Wolfe The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic Ann Rheum Dis 56 4 1997 268 271
51. D.L. Goldenberg, D. Clauw, and M. Fitzcharles How to use the new ACR Fibromyalgia diagnostic criteria Arthritis Care Res 63 7 2011 1073 1074
52. F. Wolfe, D.J. Clauw, and M.A. Fitzcharles Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia J Rheumatol 38 6 2011 1113 1122
53. F. Wolfe, D.J. Clauw, and M.A. Fitzcharles The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity Arthritis Care Res. (Hoboken) 62 5 2010 600 610
54. F. Wolfe Fibromyalgianess Arthritis Rheum 61 6 2009 715 716
55. A.B. Chandran, C.D. Coon, S.A. Martin, L.D. McLeod, T.M. Coles, and L.M. Arnold Sphygmomanometry-evoked allodynia in chronic pain patients with and without fibromyalgia Nurs Res 61 5 2012 363 368
56. N.M. Hadler "Fibromyalgia" and the medicalization of misery J Rheumatol 30 8 2003 1668 1670
57. L. Annemans, S. Wessely, and E. Spaepen Health economic consequences related to the diagnosis of fibromyalgia syndrome Arthritis Rheum 58 3 2008 895 902
58. M.A. Fitzcharles, P.A. Ste-Marie, D.L. Goldenberg National Fibromyalgia Guideline Advisory Panel 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary Pain Res Manag 18 3 2013 119 126
59. D.A. Williams, M.A. Cary, L.J. Glazer, A.M. Rodriguez, and D.J. Clauw Randomized controlled trial of CBT to improve functional status in fibromyalgia Arthritis Rheum 43 suppl S9 2000 S210
60. D.L. Goldenberg, C. Burckhardt, and L. Crofford Management of fibromyalgia syndrome JAMA 292 19 2004 2388 2395
61. D.A. Williams, D. Kuper, M. Segar, N. Mohan, M. Sheth, and D.J. Clauw Internet-enhanced management of fibromyalgia: a randomized controlled trial Pain 151 3 2010 694 702
62. S.D. Mist, K.A. Firestone, and K.D. Jones Complementary and alternative exercise for fibromyalgia: a meta-analysis J Pain Res 6 2013 247 260
63. Y.C. Lee, N.J. Nassikas, and D.J. Clauw The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia Arthritis Res Ther 13 2 2011 211
64. G. Affaitati, R. Costantini, A. Fabrizio, D. Lapenna, E. Tafuri, and M.A. Giamberardino Effects of treatment of peripheral pain generators in fibromyalgia patients Eur J Pain 15 1 2011 61 69
65. X.J. Caro, E.F. Winter, and A.J. Dumas A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg Rheumatology (Oxford) 47 2 2008 208 211
66. J.A. Williams, M. Imamura, and F. Fregni Updates on the use of non-invasive brain stimulation in physical and rehabilitation medicine J Rehabil Med 41 5 2009 305 311
67. B.R. Foerster, T.D. Nascimento, and M. DeBoer Excitatory and inhibitory brain metabolites as targets of motor cortex transcranial direct current stimulation therapy and predictors of its efficacy in fibromyalgia Arthritis Rheumatol 67 2 2015 576 581
68. W. Hauser, F. Petzke, and C. Sommer Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome J Pain 11 6 2010 505 521
69. L.M. Arnold Duloxetine and other antidepressants in the treatment of patients with fibromyalgia Pain Med 8 suppl 2 2007 S63 S74
70. T.G. Tzellos, K.A. Toulis, and D.G. Goulis Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis J Clin Pharm Ther 35 6 2010 639 656
71. L.M. Arnold, D.J. Clauw, and M.M. Wohlreich Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials Prim Care Companion J Clin Psychiatry 11 5 2009 237 244
72. M.E. Geisser, R.H. Palmer, R.M. Gendreau, Y. Wang, and D.J. Clauw A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia Pain Pract 11 2 2011 120 131
73. L.M. Arnold, E.V. Hess, J.I. Hudson, J.A. Welge, S.E. Berno, and P.E. Keck Jr. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia Am J Med 112 3 2002 191 197
74. L.M. Arnold, I. Hirsch, P. Sanders, A. Ellis, and B. Hughes Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial Arthritis Rheum 64 7 2012 2387 2397
75. R.Q. Skrabek, L. Galimova, K. Ethans, and D. Perry Nabilone for the treatment of pain in fibromyalgia J Pain 9 2 2008 164 173
76. B. Olivan-Blázquez, P. Herrera-Mercadal, and M. Puebla-Guedea Efficacy of memantine in the treatment of fibromyalgia: a double-blind, randomised, controlled trial with 6-month follow-up Pain 155 12 2014 2517 2525
77. D.J. Clauw Pain management: fibromyalgia drugs are 'as good as it gets' in chronic pain Nat Rev Rheumatol 6 8 2010 439 440
78. W. Häuser, K. Bernardy, B. Arnold, M. Offenbächer, and M. Schiltenwolf Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials Arthritis Rheum 61 2 2009 216 224
79. W. Häuser, P. Klose, and J. Langhorst Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials Arthritis Res Ther 12 3 2010 R79
80. K. Bernardy, N. Füber, V. Köllner, and W. Häuser Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - a systematic review and metaanalysis of randomized controlled trials J Rheumatol 37 10 2010 1991 2005
81. N.S. Porter, L.A. Jason, A. Boulton, N. Bothne, and B. Coleman Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia J Altern Complement Med 16 3 2010 235 249
82. J.B. Hargrove, R.M. Bennett, D.G. Simons, S.J. Smith, S. Nagpal, and D.E. Deering A randomized placebo-controlled study of noninvasive cortical electrostimulation in the treatment of fibromyalgia patients Pain Med 13 1 2012 115 124
83. L.M. Arnold, P.E. Keck Jr., and J.A. Welge Antidepressant treatment of fibromyalgia: a meta-analysis and review Psychosomatics 41 2 2000 104 113
84. W. Häuser, K. Bernardy, N. Uçeyler, and C. Sommer Treatment of fibromyalgia syndrome with gabapentin and pregabalin - a meta-analysis of randomized controlled trials Pain 145 1-2 2009 69 81
85. J. Younger, N. Noor, R. McCue, and S. Mackey Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels Arthritis Rheum 65 2 2013 529 538
86. M.E. Lynch, and F. Campbell Cannabinoids for treatment of chronic non-cancer pain: a systematic review of randomized trials Br J Clin Pharmacol 72 5 2011 735 744